Champions Oncology (CSBR) EBT Growth (3y) (2013 - 2026)
Champions Oncology (CSBR) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 6.22% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.16% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 103.69% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 24.03% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 41.79% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 38.36% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 64.03% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -38.56% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -27.69% |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | 42.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 42.03% |
| Jan 31, 2026 | 53.92% |
| Oct 31, 2025 | 405.93% |
| Jul 31, 2025 | -14.39% |
| Apr 30, 2025 | -78.38% |
| Jan 31, 2025 | 78.23% |
| Oct 31, 2024 | 36.75% |
| Jul 31, 2024 | 118.58% |
| Apr 30, 2024 | 33.32% |
| Jan 31, 2024 | -66.14% |
| Oct 31, 2023 | -407.55% |
| Jul 31, 2023 | -213.60% |
| Apr 30, 2023 | -7.02% |
| Jan 31, 2023 | -98.15% |
| Oct 31, 2022 | -26.12% |
| Jul 31, 2022 | 21.57% |
| Apr 30, 2022 | -32.13% |
| Jan 31, 2022 | 60.86% |
| Oct 31, 2021 | 2.55% |
| Jul 31, 2021 | -32.53% |